Did you know? You can suggest edits to improve this peptide information.
Overview
What is L-Carnitine?
L-Carnitine (levocarnitine) is a naturally occurring amino acid derivative essential for transporting long-chain fatty acids into mitochondria for energy production via beta-oxidation. Synthesized endogenously from lysine and methionine, it plays critical roles in energy metabolism, particularly in high-energy tissues like heart, brain, and skeletal muscle. FDA approved as Carnitor® for treating primary and secondary carnitine deficiency. Various forms exist including Acetyl-L-Carnitine (ALCAR) for cognitive support, L-Carnitine L-Tartrate (LCLT) for exercise recovery, and Propionyl-L-Carnitine for cardiovascular health. Extensively studied with over 200 clinical trials examining effects on weight management, exercise performance, heart health, cognitive function, and male fertility.
Key Benefits
Maximum bioavailability (100% vs 14-18% oral), rapid onset of action, bypasses gut microbiome conversion to TMAO, particularly useful for carnitine deficiency states and clinical settings.
Mechanism of Action
Injectable L-Carnitine delivers the compound directly to circulation, bypassing the limitations of intestinal absorption. This provides immediate availability for fatty acid transport into mitochondria. IV/IM routes are preferred in clinical settings for carnitine deficiency and dialysis patients.
Research Indications
Carnitine Deficiency
FDA-approved indication for primary and secondary carnitine deficiency. Injectable form provides 100% bioavailability for rapid repletion of carnitine stores.
Dialysis Support
FDA-approved for end-stage renal disease patients on hemodialysis who lose carnitine during dialysis sessions. Standard protocol is 10-20 mg/kg post-dialysis.
Fat Metabolism
Direct delivery supports enhanced fatty acid oxidation and energy production, particularly beneficial when combined with exercise protocols.
Research Protocols
Disclaimer
Injectable L-Carnitine is FDA-approved for carnitine deficiency and dialysis patients. For wellness/performance use, typical protocols range from 500-1500mg IM 2-3x weekly. No cycling is required for therapeutic use; performance protocols often run 8-12 weeks. This is not medical advice. Consult a healthcare provider before use.
Timing
Injectable L-Carnitine can be administered any time. For exercise performance, some protocols administer 1-2 hours before training. For dialysis patients, administer into venous return line post-session.
Peptide Interactions
How to Reconstitute
Important
L-Carnitine injectable comes as a pre-mixed sterile solution and does not require reconstitution. Simply draw from vial and administer.
L-Carnitine injectable typically comes pre-mixed as a sterile solution
Check solution clarity - should be clear and colorless
For IV: May be diluted in normal saline for infusion
For IM: Draw appropriate volume directly from vial
Clean injection site thoroughly with alcohol
Administer slowly - IV bolus over 2-3 minutes minimum
Quality Indicators
Clear, Colorless Solution
Injectable L-Carnitine should be a clear, colorless to slightly yellow solution with no particles or cloudiness.
Proper Packaging
Should come in sealed sterile vials with proper pharmaceutical labeling, lot number, and expiration date.
Slight Yellow Tint
A very slight yellow color may be acceptable but check manufacturer specifications. Solution should still be clear.
Cloudy or Particulate
Any cloudiness, particles, or precipitates indicate contamination or degradation - do not use.
Damaged Seal
Never use vials with compromised seals or visible damage. Sterility cannot be assured.
What to Expect
- Immediate: 100% bioavailability and rapid tissue distribution
- Days 1-7: Normalized carnitine levels, potential energy improvements
- Weeks 2-4: Enhanced fat utilization during exercise, improved recovery
- Weeks 4-8: Sustained metabolic benefits, potential body composition changes
- Side effects: Injection site reactions (mild), fishy body odor at high doses
Side Effects & Safety
- FDA-approved for specific indications - well-established safety profile
- May cause injection site discomfort or temporary warmth
- High doses can cause fishy body odor due to TMA production
- Use caution in hypothyroidism - may inhibit thyroid hormone action
- Monitor if on anticoagulants (warfarin) - may enhance effect
- Renal patients should be monitored for TMA/TMAO accumulation
References
Weight Loss Meta-Analysis (2020)
Comprehensive meta-analysis showing L-Carnitine supplementation significantly decreased body weight (−1.21 kg), BMI (−0.24 kg/m²), and fat mass (−2.08 kg). Non-linear dose-response analysis suggested 2000 mg/day provides maximum effect.
View Study (opens in new tab) →Cardiovascular Secondary Prevention (2013)
Mayo Clinic meta-analysis found L-Carnitine associated with 27% reduction in all-cause mortality, 65% reduction in ventricular arrhythmias, and 40% reduction in angina development in acute myocardial infarction patients.
View Study (opens in new tab) →Exercise Recovery LCLT Study (2021)
L-Carnitine L-Tartrate supplementation for 5 weeks improved perceived recovery and soreness (p=0.021) and lowered serum creatine kinase (p=0.016) following high-volume exercise challenge.
View Study (opens in new tab) →Quick Start Guide
Community Poll
Question 1 of 10
What is your experience with this compound?
Poll Results
Loading results...
Community Insights
Self-reported by Nootpedia users. Not clinical evidence. Health changes reflect all users, including those taking multiple compounds.
Was this helpful?
Your feedback helps us improve Nootpedia